Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Abraxis BioScience Announces Date for Fourth Quarter and Full Year Financial Results and Investor Conference Call.


LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:ABBI Advanced Breast Biopsy Instrument (ABBI)
Uses a rotating circular knife and thin heated electrical wire to remove a large cylinder of abnormal breast tissue.

Mentioned in: Fibrocystic Condition of the Breast
), an integrated, global biopharmaceutical company, today announced it will release its 2006 fourth quarter and full-year financial results before the market opens on Monday, February 26, 2007. The company also said that senior management will host an investor conference call that same day at 8:30 a.m. PT/11:30 a.m. ET to review the company's financial results and operations.

The conference call will be available to interested parties through a live audio webcast at www.abraxisbio.com and www.earnings.com. The call will also be archived and accessible at both sites for six months.

About Abraxis BioScience, Inc.

Abraxis BioScience, Inc. is an integrated global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures and markets one of the broadest portfolios of injectable products and leverages revolutionary technology such as its nab platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approved product to use this nab platform, ABRAXANE([R]), was launched in 2005 for the treatment of metastatic Metastatic
The term used to describe a secondary cancer, or one that has spread from one area of the body to another.

Mentioned in: Coagulation Disorders


metastatic

pertaining to or of the nature of a metastasis.
 breast cancer. Abraxis trades on the NASDAQ Stock Market Nasdaq stock market

The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies.
 under the symbol ABBI. For more information about the company and its products, please visit www.abraxisbio.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 6, 2007
Words:214
Previous Article:International Rectifier Named as Finalist in Three EDN Innovation Award Categories.
Next Article:Swedish Armed Forces Chooses Red Hat and Open Source.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles